Metraipolis › archive › dc_debc2b68b51e
Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming — Europe PMC PMID:41304988
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41304988
- DOI
- 10.3390/ph18111747
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T12:19:59.493Z
- SHA-256 of the archived text
e77e756a342b3b47eaff766ab7f0f8a91c583230641deb5f7809480ac5d980e1- Stable URL of this page
https://metraipolis.com/documento/dc_debc2b68b51e
How to cite
Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming — Europe PMC PMID:41304988 — Europe PMC (en), https://europepmc.org/article/MED/41304988 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_debc2b68b51e (Metraipolis archive dc_debc2b68b51e, sha256 e77e756a342b3b47eaff766ab7f0f8a91c583230641deb5f7809480ac5d980e1)
BibTeX
@misc{dcdebc2b68b51e,
title = {Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming — Europe PMC PMID:41304988},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41304988},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_debc2b68b51e; sha256 e77e756a342b3b47eaff766ab7f0f8a91c583230641deb5f7809480ac5d980e1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304988. Agents can read the archived copy with the MCP tool read_document.